FVIII, the blood clotting protein missing in hemophilia A, adopts multiple shapes, making it more likely to be targeted by ...

A man’s acquired hemophilia coincided with a rare liver disease, a connection that had not been reported before, per a case ...

Columnist G Shellye Horowitz is looking for a new factor product after the one she was trying had disappointing results.

It can be tempting to compare your life with others, columnist Cazandra Campos-MacDonald writes, but the grass isn't always greener.

A therapy to boost the production of regulatory T-cells prevented inhibitor formation in a mouse model of hemophilia A, per a ...

In part two of a series, columnist Jennifer Lynne talks with Chip Hailey about his experience receiving gene therapy for hemophilia B.

As her sons with hemophilia step into their futures prepared for what comes, columnist Cazandra Campos-MacDonald is embracing ...

The FDA has extended its approval of Jivi to cover the therapy's use in children with hemophilia A ages 7 years and older.

Many of my recent columns have focused on my youngest son, Caeleb, and his transition into adulthood. I’ve shared how we’ve empowered him to live his best life, including lessons on taking ...

Columnist G Shellye Horowitz argues for a new way of classifying hemophilia severity that takes both genotype and phenotype into account.